Atezolizumab
Atezolizumab
Immunoglobulin G1, anti-(human cd antigen cd274) (human monoclonal MPDL3280A heavy chain), disulfide with human monoclonal MPDL3280A kappa-chain, dimer
Stoffgruppe
Antineoplastisches Mittel (Checkpoint-Inhibitor)
Halbwertszeit
27 Tage
Hämodialyse
nein